M&A Deal Summary |
|
|---|---|
| Date | 2007-02-28 |
| Target | Buch und Kunst und Co. KG |
| Sector | Retail |
| Buyer(s) | Thalia bookstore BOOK & ART & Co. KG |
| Sellers(s) | Equistone |
| Deal Type | Add-on Acquisition |
SEARCH BY
Thalia bookstore BOOK & ART GmbH & Co. KG is a online bookselling chain.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Retail M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: Germany M&A | 1 of 1 |
| Year: 2007 M&A | 1 of 1 |
| Category | Private Equity Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 9.6B EUR |
| Size | Mega |
| Type | Sector Agnostic |
Equistone is a private equity firm that invests in small to mid-sized companies valued from €50 to €500 million. Equistone targets companies operating in the fields of services, healthcare, financial services, and consumer/travel. The Firm looks to invest €25 to €200 million in a variety of transactions, including buyouts, growth capital financings, recapitalizations, and take privates. Equistone was formed in 1997 and is based in London, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 68 of 206 |
| Sector: Retail M&A | 3 of 14 |
| Type: Add-on Acquisition M&A Deals | 27 of 70 |
| Country: Germany M&A | 7 of 34 |
| Year: 2007 M&A | 3 of 11 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-02-06 |
Desmet Ballestra
Graz, Austria Desmet Ballestra is specialised in the fields of engineering and supply of plant and equipment for the edible oil industry, the detergent-surfactants and relating chemical industry, the oleochemical and biodiesel industry. The Group is the result of the merge in 2006 of 2 EP leaders in their respective fields: Desmet and Ballestra. Desmet Ballestra was founded in 1987 and is based in Graz, Austria. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-03-01 |
Médi-Partenaires SAS
Paris, France Médi-Partenaires is the third largest group of private clinics in France, with 3% market share and 14 clinics focusing on obstetrics, surgery and medicine care. |
Sell | €600M |
